Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HO2T: Hyperoxic vs Normoxic Oxygen Therapy in Sepsis
NCT02378545Phase 4Completed
- Sponsor
- University Hospitals Plymouth
- Start
- Oct 2015
- Primary completion
- Oct 2016
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of oxygen in sepsis, sponsored by University Hospitals Plymouth. Primary endpoint: Mortality at 90 days. Started Oct 2015; status: completed.
02
Drugs
oxygen
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT02378545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02378545.